- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Arch Biopartners Inc (ARCH)
Arch Biopartners Inc stock price live, this page displays TSXV ARCH stock exchange data. View the ARCH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Arch Biopartners Inc real time stock price chart below.
What Is the Arch Biopartners Inc Stock Price Today?
The Arch Biopartners Inc stock price today is 1.73.
What Is the Stock Symbol for Arch Biopartners Inc?
The stock symbol for Arch Biopartners Inc is ""ARCH.""
What Stock Exchange Does Arch Biopartners Inc Trade On?
Arch Biopartners Inc is listed and trades on the TSXV stock exchange.
Is Arch Biopartners Inc a Good Stock to Buy?
Determining whether Arch Biopartners Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARCH quote. (ISIN: CA03938C1041)
What Is the Arch Biopartners Inc Stock Price Today?
The Arch Biopartners Inc stock price today is 1.73.
What Is the Stock Symbol for Arch Biopartners Inc?
The stock symbol for Arch Biopartners Inc is ""ARCH.""
What Stock Exchange Does Arch Biopartners Inc Trade On?
Arch Biopartners Inc is listed and trades on the TSXV stock exchange.
Is Arch Biopartners Inc a Good Stock to Buy?
Determining whether Arch Biopartners Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARCH quote. (ISIN: CA03938C1041)
TSXV
Currency in CAD
1.73
-0.02(-1.14%)
Closed·
Fair Value
An estimate of a Arch Biopartners's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.71
1.75
52 wk Range
1.27
2.20
ARCH Scorecard
Full Analysis
Net income is expected to drop this year
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a Arch Biopartners's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.711.75
52 wk Range
1.272.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ARCH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Arch Biopartners's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Arch Biopartners Inc Company Profile
Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which is in Phase 2 trials to treat inflammation related acute kidney injury experienced by patients undergoing on-pump (bypass) cardiac surgery; and cilastatin to prevent toxin related acute kidney injury via dipeptidase-1. The company also develops AB569 for treating antibiotic-resistant bacterial infections and as a topical treatment for wounds; and Borg, a peptide-solid surface interface, which are binding of proprietary peptides to solid metal and plastic surfaces to inhibit biofilm formation and to reduce corrosion. Arch Biopartners Inc. is based in Toronto, Canada.
Compare ARCH to Peers and Sector
Metrics to compare | ARCH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARCHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −37.9x | −5.7x | −0.5x | |
PEG Ratio | 0.98 | 0.00 | 0.00 | |
Price/Book | −30.5x | 1.3x | 2.6x | |
Price / LTM Sales | −472.7x | 1.2x | 3.3x | |
Upside (Analyst Target) | - | 96.5% | 40.3% | |
Fair Value Upside | Unlock | −1.7% | 4.7% | Unlock |
Earnings
Latest Release
Jun 02, 2025
EPS / Forecast
-0.009 / -0.02
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Arch Biopartners Trade On?
Arch Biopartners is listed and trades on the TSX Venture Exchange stock exchange.
What Is the Stock Symbol for Arch Biopartners?
The stock symbol for Arch Biopartners is "ARCH."
What Is the Arch Biopartners Market Cap?
As of today, Arch Biopartners market cap is 105.10M.
What Is Arch Biopartners's Earnings Per Share (TTM)?
The Arch Biopartners EPS (TTM) is -0.05.
When Is the Next Arch Biopartners Earnings Date?
Arch Biopartners will release its next earnings report on 26 Aug 2025.
From a Technical Analysis Perspective, Is ARCH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Arch Biopartners Stock Split?
Arch Biopartners has split 1 times.
How Many Employees Does Arch Biopartners Have?
Arch Biopartners has 0 employees.
What is the current trading status of Arch Biopartners (ARCH)?
As of 14 Aug 2025, Arch Biopartners (ARCH) is trading at a price of 1.73, with a previous close of 1.75. The stock has fluctuated within a day range of 1.71 to 1.75, while its 52-week range spans from 1.27 to 2.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.